[1] That pharmacology creates a predictable psychological trap: you stop injections, nothing dramatic happens immediately, you assume you are safe, and then appetite and food noise surge later, right when motivation is lowest
Thymosins in multiple sclerosis and its experimental models: Moving from basic to clinical application
Of adults receiving tirzepatide who had no or minimal depression symptoms at baseline, 79.4% remained in that category through the end of safety follow-up, 17% reported mild depression symptoms, 2.9% had moderate symptoms, 0.7% reported moderately severe symptoms and 0.1% had severe symptoms
GLP-1 RAs have been associated with the development of pancreatitis
Insurance approval depends on your plan's formulary rules, prior authorization requirements, and whether your BMI or weight-related health conditions meet coverage thresholds